Colinz Laboratories Ltd
BSE:531210
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Colinz Laboratories Ltd
Deferred Income Tax
Colinz Laboratories Ltd
Deferred Income Tax Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Deferred Income Tax | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Colinz Laboratories Ltd
BSE:531210
|
Deferred Income Tax
₹2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-7%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Deferred Income Tax
₹14.8B
|
CAGR 3-Years
874%
|
CAGR 5-Years
258%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Deferred Income Tax
₹416.8m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-20%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Deferred Income Tax
₹3.9B
|
CAGR 3-Years
130%
|
CAGR 5-Years
55%
|
CAGR 10-Years
22%
|
|
|
Lupin Ltd
NSE:LUPIN
|
Deferred Income Tax
₹2.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Deferred Income Tax
₹7.9B
|
CAGR 3-Years
37%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
11%
|
|
Colinz Laboratories Ltd
Glance View
Colinz Laboratories Ltd. engages in the manufacture of pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectable, ointments, and creams. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2004-01-13. The firm operates and supplies medicines in the domestic market. The Company’s products include oncology, ayurvedic and nutraceuticals. Its oncology products include imatinib, erlotinib, letrozole, exemestane, bortezomib, fludarabine phosphate, doxorubicin, filgrastim and pegylated liposome doxorubicin. Its ayurvedic products include anti-diarrheas, anti-pyrectics, anti-inflammatories, anti-spasmodic, cough syrups, appetite stimulating agents, memory boosters, anti-piles, antacids, liver tonic, ulcer healing agents, digestive agents, drugs to treat oligospermia and erectile dysfunction, ear drops, uterine tonic, anti-diabetics, and general tonics.
See Also
What is Colinz Laboratories Ltd's Deferred Income Tax?
Deferred Income Tax
2m
INR
Based on the financial report for Dec 31, 2025, Colinz Laboratories Ltd's Deferred Income Tax amounts to 2m INR.
What is Colinz Laboratories Ltd's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 10Y
-7%
Over the last year, the Deferred Income Tax growth was -17%. The average annual Deferred Income Tax growth rates for Colinz Laboratories Ltd have been -4% over the past three years , -5% over the past five years , and -7% over the past ten years .
